During the past decade, Studium Egeszseghaz Kft conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studium Egeszseghaz Kft" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Studium Egeszseghaz Kft" are "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials), "Obesity" (1 trials), "Overweight and Obesity" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Studium Egeszseghaz Kft" in a lesser frequency.

Most popular intervention types in "Studium Egeszseghaz Kft" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dulaglutide" (1 trials), "Edoxaban" (1 trials), "Empagliflozin" (1 trials) and "LY3502970" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studium Egeszseghaz Kft" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Studium Egeszseghaz Kft". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Studium Egeszseghaz Kft, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Studium Egeszseghaz Kft, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".